Ultragenyx Pharmaceutical's market cap is currently $2.91B. The company's EPS TTM is $-1.17; its P/E ratio is ―; Ultragenyx Pharmaceutical is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $-1.23. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in USD
Ultragenyx Pharmaceutical Earnings and Revenue History
